✦ LIBER ✦

Implications of therapy choice on overall survival in metastatic renal cell carcinoma

✍ Scribed by Simrit Parmar; Alfred W. Rademaker; Bing B. Fung; James M. Kozlowski; Timothy M. Kuzel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Progression-free survival as a predictor

✍ Daniel Y. C. Heng; Wanling Xie; Georg A. Bjarnason; Ulka Vaishampayan; Min-Han T 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

Have Molecularly Targeted Therapies Impr

✍ Michel Choueiri; Eric Jonasch 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 93 KB

Update on systemic therapies of metastat

✍ E. Herrmann; S. Bierer; C. Wülfing 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 257 KB

An update on targeted therapy in metasta

✍ Giuseppe Lombardi; Fable Zustovich; Martin Donach; Maurizia Dalla Palma; Ornella 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 321 KB

1140 Categories of response to first lin

✍ Busch, J.F.; Seidel, C.; Goranova, I.; Erber, B.; Peters, R.; Friedersdorff, F.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 108 KB

O5 Progression free survival (PFS) and o

✍ Iacovelli, R.; Milella, M.; Santoni, M.; Di Lorenzo, G.; Cerbone, L.; Ortega, C. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 172 KB